Viewing StudyNCT00217581



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00217581
Status: COMPLETED
Last Update Posted: 2019-03-26
First Post: 2005-09-20

Brief Title: Bevacizumab Oxaliplatin and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization: Barbara Ann Karmanos Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Gastric Cancer
Esophageal Cancer
Keywords:
Name View
recurrent gastric cancer View
stage III gastric cancer View
stage IV gastric cancer View
recurrent esophageal cancer View
stage III esophageal cancer View
stage IV esophageal cancer View
adenocarcinoma of the stomach View